Latest News Releases From The Newsroom
Mallinckrodt Eyes Chapter 11; Peloton Posts Q4 Loss, Reveals Downbeat Forecast
August 23rd, 2023
Mallinckrodt plc (NYSE American: MNK) said that it has entered into a Restructuring Support Agreement (RSA) with a significant majority of its debtholders and the Opioid Master Disbursement Trust II. The plan aims to reduce the company's debt by arou. Read more
Abercrombie & Fitch Beats Expectations; Foot Locker Posts Mixed Results, Outlook Falls Short
August 23rd, 2023
Abercrombie & Fitch Co. (NYSE: ANF), a well-known apparel retailer, reported second-quarter fiscal 2023 adjusted earnings of $1.10 per share, surpassing the consensus EPS estimate of $0.17. The company's quarterly sales reached $935.30 million, excee. Read more
Market Buzz: Dycom Beats Q2 Estimates; Bullish Stance on Safehold
August 23rd, 2023
Dycom Industries, Inc. (NYSE: DY), a significant player in the infrastructure and specialty contracting sector, reported second-quarter fiscal 2024 earnings of $2.03 per share, surpassing the consensus EPS estimate of $1.66. The company's quarterly s. Read more
Grab Holdings, Bath & Body Works, and Abercrombie & Fitch's Earnings Preview
August 22nd, 2023
Several companies are gearing up to unveil their financial results on Wednesday, August 23, including: Grab Holdings Limited (Nasdaq: GRAB), a significant player in the technology and ride-hailing industry, is set to release its unaudited second q. Read more
Earnings Reactions: Toll Brothers and Urban Outfitters Beat Estimates
August 22nd, 2023
Toll Brothers, Inc. (NYSE: TOL), a prominent luxury homebuilder, reported third-quarter fiscal 2023 earnings of $3.73 per share, surpassing the consensus EPS estimate of $2.81. The company's quarterly sales reached $2.69 billion, exceeding analysts' . Read more
FDA’s Decision Boosts Fulcrum Therapeutics; Macy’s Beats Q2 Estimates
August 22nd, 2023
Shares of Fulcrum Therapeutics, Inc. (Nasdaq: FULC) surged over 30% in pre-market trading following the announcement that the U.S. Food and Drug Administration (FDA) has lifted the clinical hold on the Investigational New Drug (IND) application for F. Read more
Breaking: Microsoft's Reconstructed Activision Bid Under UK's CMA Examination
August 22nd, 2023
The UK's Competition and Markets Authority (CMA) has initiated a phase 1 investigation into Microsoft Corporation's (Nasdaq: MSFT) restructured deal to acquire Activision Blizzard, Inc. (Nasdaq: ATVI). This comes after the CMA previously blocked the . Read more
Baidu and iQIYI Outperform Wall Street Expectations
August 22nd, 2023
Baidu, Inc. (Nasdaq: BIDU), a leading Chinese technology company, unveiled second-quarter 2023 earnings per American depositary share (ADS) of $3.11, outperforming the consensus estimate of $2.32. The company's quarterly sales reached $4.70 billion, . Read more
Lockheed Martin Bags $347M+ Contract Modification; Nordson Posts Mixed Results, Outlook Disappoints
August 22nd, 2023
Lockheed Martin Aeronautics Company, a major division of Lockheed Martin Corporation (NYSE: LMT), has secured a $347,435,068 firm-fixed-price modification to a previously awarded indefinite-delivery/indefinite-quantity contract. This addition expands. Read more
$20.4M Financing Fuels ProMIS Neurosciences; Dragonfly Energy Misses Estimates
August 21st, 2023
Shares of ProMIS Neurosciences Inc. (Nasdaq: PMN) surged over 20% in after-hours trading following the announcement of a private investment financing for gross proceeds of approximately $20.4 million. The financing is set to conclude on August 23, 20. Read more
Want To Find Some News?
News By Industries
Recent Posts
-
February 27th, 2026February 26th, 2026
Treasury Sanctions Nicaraguan Officials Enabling the Murillo-Ortega Dictatorship's Repression
February 26th, 2026Kansas City Storm Names Cecil Stockdale as Head Coach for 2026 NJCP Season
February 26th, 2026




Member Login